It can be done. Where's a will there's a way.
Lantheus increases to 12.16% shareholding in Radiopharm with
US$5m (A$8m) placement at 150% premium
Private placement to radiopharmaceutical industry leader Lantheus, for US$5.0 million
Placement at A$0.060 per share, representing a premium of 150% to the last closing price
of A$0.024
Lantheus shareholding in Radiopharm increases to 12.16% following the placement
The funds raised will be applied to the development of Radiopharm’s clinical pipeline
CHM needs a RAD-style deal.
It can be done. Where's a will there's a way.Lantheus increases...
Add to My Watchlist
What is My Watchlist?
